Searched for
PLAQUES PSORIASIS TREATMENT
Sun Pharma sees steady FY27 growth, progresses $11.75 bn Organon integration dealSun Pharma anticipates strong growth in the coming years. The company expects a high single-digit increase in its overall sales by FY2027. ...- Sun Pharma launches Ilumya for psoriasis treatment in IndiaSun Pharmaceutical Industries has launched its innovative drug Ilumya in India. This medication treats moderate-to-severe plaque psoriasis....
- Sun Pharma brings global psoriasis drug ILUMYA to Indian marketSun Pharmaceutical Industries has launched its innovative biologic drug, ILUMYA, in India for moderate-to-severe plaque psoriasis. This nov...
- Eli Lilly forays into dermatological space with launch of psoriasis drugEli Lilly has launched a new drug to treat moderate-to-severe plaque psoriasis in India. The drug, Copellor, is designed to specifically ta...
- Unichem Laboratories gets USFDA nod for plaque psoriasis treatment drugApremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for photot...
- Sun Pharma arm launches plaque psoriasis treatment drug in JapanIn a regulatory filing, Sun Pharmaceutical Industries said its "wholly-owned Japanese subsidiary has launched Ilumya Subcutaneous Injection...
- Sun Pharma, Hikma ink exclusive pact for plaque psoriasis drug for MENA regionUnder the terms of the licensing agreement, Hikma will be responsible for the registration and commercialisation of the product in all MENA...
- Alembic Pharma JV gets USFDA nod for plaque psoriasis treatment drugAlembic has a cumulative total of 103 ANDA approvals (91 final approvals and 12 tentative approvals) from USFDA.
- New psoriasis drug study yields positive results: Dr Reddy'sAccording to a press release from the city-based drug-maker, the detailed safety and efficacy data from the study would be presented in fut...
- Sun Pharma jumps 2% as partner gets drug nodThe stock rose 2.28 per cent to hit a high of Rs 657 on the BSE.
- Lupin launches plaque psoriasis treatment spray in US marketQuoting IQVIA MAT May 2018 data, Lupin said Desoximetasone Topical Spray, 0.25 per cent, had annual sales of approximately USD 18.7 million...
- Tildra approval to give sentimental push to Sun PharmaThe drug which will be sold under the brand name Ilumya is expected to treat adults for moderate to severe plaque psoriasis, an autoimmune ...
- Sun Pharma signs licening pact with spanish firm Almirall for psoriasis drugIn return, the Indian company will receive an initial upfront payment of $50 million and be eligible for development and regulatory milesto...
- Novartis Healthcare launches psoriasis treatment drug in IndiaNovartis Healthcare has launched secukinumab, used for the treatment of plaque psoriasis in adult patients, in India. The company has launc...
- Glenmark gets tentative USFDA nod for generic psoriasis creamGlenmark said in a statement that the product is the therapeutic equivalent of Danish pharma firm Leo Pharma A/S Dovonex's topical cream of...
- Sun Pharmaceutical shares end nearly 2 per cent up on Merck & Co Inc licensing pactStock of the pharma firm settled with a gain of 1.63 per cent at Rs 805.20 on the BSE. During the day, it climbed 2.78 per cent to Rs 814.4...
- Sun Pharma, Merck & Co Inc enter into pact for TildrakizumabUnder terms of the agreement, Sun Pharma will acquire worldwide rights to tildrakizumab for use in all human indications from Merck.
- Biocon to launch psoriasis drug novel biologic in JulyThe company had received marketing authorisation for Itolizumab from the Drugs Controller General of India (DCGI) in January, 2013.
- Biocon gets DCGI approval to market anti-psoriasis drug, Itolizumab"The company has received market authorisation from the DCGI for its novel biologic Itolizumab, for treatment of chronic plaque psoriasis,"...
- Govt to share Lupin's migraineThe government's Department of Science and Technology (DST) has committed over Rs 10 crore to support drug maker Lupin's two clinical devel...
Load More
